Bausch Health Companies Shareholder Engagement Presentation Deck

18 Reconciliation: Organic growth¹ Bauch +Lomb4 Global Vision Care Global Surgical Global Consumer4 Global Ophtho Rxª Total Bausch + Lomb Bausch Pharma5 Salix Salix International Rx4 International Rx Ortho Dermatologics4 Ortho Dermatologics4 Global Solta Total Ortho Dermatologics Diversified Products Neurology & Other4 Generics4 Dentistry Total Diversified Products Bausch Pharma revenues Total Bausch Health revenues Revenue as Reported 893 718 1,450 704 3,765 2,074 1,166 256 308 564 593 171 101 865 4,669 $ 8,434 Calculation of Organic Revenue for the Twelve Months Ended December 31, 2021 December 31, 2020 Changes in Exchange Rates³ $ (10) (20) (18) (10) (58) (28) (9) (9) (37) (95) Organic Revenue (Non- GAAP) 1,2 $ 883 698 1,432 694 3,707 2,074 1,138 256 299 555 593 171 101 865 4,632 8,339 Revenue as Reported 755 576 1,354 730 3,415 1,904 1,181 295 253 548 666 240 73 979 4,612 $ 8,027 Divestitures and Discontinuations $ (1) (1) (10) (113) (9) (122) (132) $ Organic Revenue (Non- GAAP) 1,2 752 571 1,353 729 3,405 1,904 1,068 295 253 548 659 238 73 970 4,490 7,895 $ Change in Reported Revenue Amount 138 142 96 (26) 350 170 (15) (39) 55 16 (73) (69) 28 (114) 57 407 1. This is a non-GAAP measure or non-GAAP ratio. See the remainder of this Appendix for further information on non-GAAP measures and ratios, including reconciliations of historic non-GAAP measures to their most directly comparable GAAP measure. 2. Organic growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations. 3. The impact for changes in foreign currency exchange rates is determined as the difference in the current period reported revenues at their current period currency exchange rates and the current period reported revenues revalued using the monthly average currency exchange rates during the comparable prior period. 4. Reserved 5. Bausch Pharma revenue, a non-GAAP measure, is determined by subtracting Bausch+Lomb segment revenue for the applicable period from total Bausch Health revenue for the applicable period. Pct. 18% 25% 7% -4% 10% 9% -1% -13% 22% 3% -11% -29% 38% -12% 1% 5% Change in Organic Revenue Amount $ 131 17% 127 79 22% 6% -5% (35) 9% 302 170 Pct. 70 7% 9% (39) -13% 46 18% 7 1% 142 (66) -10% (67) -28% 28 38% (105) -11% 444 3% 6% BAUSCH- Health

View entire presentation